Skip to Content

Unraveling the HER2-Low Breast Cancer Puzzle – Treatment Sequencing and Targeted Therapies

In this MEDtalk, Hematologist Arya Mariam Roy from the Roswell Park Comprehensive Cancer Center in New York presents a review of treatment options in HER2-low breast cancer and discusses treatment sequencing algorithms.

Arya Mariam Roy

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top